Inogen

Inogen Receivables

The Accounts Receivable of Inogen (INGN) as of Oct 6, 2026 is 38.86 M USD. In the previous year, Accounts Receivable was 29.56 M USD — a change of 31.46% (higher).

Receivables

38.86 MUSD

YoY

31.46%

Last updated:

Accounts Receivable of Inogen is 2026 38.86 M USD. Accounts Receivable of Inogen was 2025 29.56 M USD. It decreases by 31.46% higher compared to the previous year.

The Inogen Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2018
37.00 M USD
Jan 1, 2019
34.30 M USD
Jan 1, 2020
29.70 M USD
Jan 1, 2021
24.50 M USD
Jan 1, 2022
62.70 M USD
Jan 1, 2023
42.24 M USD
Jan 1, 2024
29.56 M USD
Jan 1, 2025
38.86 M USD
The Inogen Receivables history
YEARReceivablesYoY
38.86 MUSD+31.46%
29.56 MUSD-30.01%
42.24 MUSD-32.63%
62.70 MUSD+155.92%
24.50 MUSD-17.51%
29.70 MUSD-13.41%
34.30 MUSD-7.30%
37.00 MUSD+17.83%
31.40 MUSD+1.95%
30.80 MUSD+54.77%
19.90 MUSD+3.11%
19.30 MUSD—
Access this data via the Eulerpool API
Get Free API Key

Inogen Stock analysis

What does Inogen do? Inogen Inc. is an American company that specializes in the development and manufacturing of oxygen concentrators. The company was founded in 2001 and is headquartered in Goleta, California. Inogen has become a market leader in portable oxygen concentrators in the American market. The company offers high-quality products and services to improve the lives of patients with chronic lung problems. Inogen focuses on improving the quality of life by developing and manufacturing high-quality, durable, and reliable portable oxygen concentrators that integrate all necessary features for optimal mobility and freedom. It offers various products and services for patients, doctors, insurance companies, and community centers. Some of its products include the Inogen One G5, Inogen One G4, Inogen TAV, Inogen Carry Bag, and Inogen Battery. In summary, Inogen Inc. is a specialized company in the development and manufacturing of oxygen concentrators, with a focus on improving the lives of patients with chronic lung problems through high-quality portable solutions. Inogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inogen stock

Accounts Receivable of Inogen is 38.86 M USD in 2026.

Accounts Receivable of Inogen changed from 29.56 M USD to 38.86 M USD, representing a 31.46% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable Inogen since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Inogen historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Inogen

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Inogen